JGJunchao Guo

Junchao Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Junchao Guo has a total of 172 co-authors. Here are the top co-authors by number of shared publications:

  • Jun Lu

    Department of General Surgery, Peking University Third Hospital, Beijing 100191, China

    24 shared publications
  • Li Zhou

    Department of General Surgery Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

    22 shared publications
  • Lei You

    General Surgery

    14 shared publications
  • Yupei Zhao

    General Surgery Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

    14 shared publications
  • Bolun Jiang

    Peking Union Medical College Hospital

    12 shared publications
  • Yizhi Wang

    Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

    12 shared publications

Latest Publications

  • Transabdominal ultrasound subclassification of pancreatic serous cystic neoplasms: correlation with MRI and characterization of subtype-specific features

    by Xiaoyi Yan, Yuming Shao, Yang Gui, Erjia Guo, Huijia Zhao, Bo Kong, Wanying Jia, Hua Liang, Menghua Dai, Weibin Wang, et al.

    Objectives To characterize the transabdominal ultrasound (US) features of pancreatic serous cystic neoplasm (SCN) morphological subtypes, evaluate US-MRI agreement, and explore reducing overtreatment. Materials and methods This retrospective study included 125 patients with pathologically confirmed pancreatic SCNs who underwent preoperative US. Lesions were morphologically classified into macrocystic, microcystic, mixed, and solid subtypes. US-MRI concordance (71 patients, 56.8%) was assessed using Cohen’s kappa. Demographics, grayscale features, and CEUS patterns (exploratory n = 14) were described. Results US demonstrated excellent agreement with MRI for SCN subtyping (κ = 0.817, 95% CI: 0.711–0.923). Macrocystic was most common (38.4%) and occurred in younger patients (42.0 ± 12.3 years, p < 0.001). Overall, exophytic growth (84.1%) was a hallmark feature. Mixed subtypes exhibited the highest lobulation rate (p < 0.001) and peripheral macrocysts, whereas solid subtypes were predominantly non-lobulated. US and MRI discrepancies arose when microcysts were too small to resolve on US, mimicking solid. On CEUS, microcystic SCNs showed honeycomb architecture, whereas solid SCNs demonstrated arterial iso- or slight hyper-enhancement followed by slow washout. Conclusion Conventional US provides reliable morphological subtyping of SCNs, comparable to MRI. Recognizing fine internal architectures, distinctive growth patterns (exophytic/lobulated), and the potential value of slow CEUS washout patterns may aid in the characterization of SCNs and provide supportive information for differential diagnosis. Given that most SCNs are benign and do not require routine intervention, improved non‑invasive characterization by US can help inform clinical decision‑making and potentially reduce surgical overtreatment.

  • Open Access

    Neutrophil‐based immunotherapy: A metabolic lens on mechanisms and therapeutic implications

    by Wenchao Xu, Yu Su, Li Zhou, Jianzhou Liu, Junchao Guo

    Background: Tumor‐associated neutrophils (TANs) serve as pivotal immune modulators in the tumor microenvironment and exert profound, context‐dependent effects on tumor immunity, yet their metabolic features and functional implications remain insufficiently explored. Main body: Throughout their lifecycle, neutrophils continuously sense and adapt to shifting microenvironments, maintaining survival and functional homeostasis through metabolic reprogramming. As key hubs of the tumor metabolic network, TANs exhibit pronounced metabolic plasticity and heterogeneity. Whether active or passive, TAN metabolic reprogramming critically contributes to immune evasion via multiple mechanisms, including regulation of immune mediator expression and intercellular metabolite crosstalk. Current research focuses on strategies that induce durable TAN metabolic reprogramming while overcoming inherent limitations, aiming to establish an efficient and safe TAN‐directed immunotherapeutic framework. In this review, we systematically summarize recent advances in TAN metabolic reprogramming, emphasizing its intrinsic link to immunological phenotypes and spatiotemporal heterogeneity. We also propose a TAN metabolic classification framework (4‐Tier TAN‐MetaC) and provide a comprehensive overview of translational opportunities, bottlenecks, and actionable future directions for TAN metabolism‐targeted immunotherapies. Conclusion: Overall, TAN metabolic reprogramming represents a central driver of tumor immune evasion and a clinically actionable metabolic vulnerability for cancer immunotherapy. Key points: Tumour‐associated neutrophil (TAN) metabolic reprogramming is tightly linked to their immunosuppressive functions. Spatiotemporal metabolic heterogeneity shapes TAN‐mediated tumour immunity. A metabolism‐based TAN stratification model unifies cross‐study frameworks. TAN metabolism‐targeted immunotherapy holds promise for improving patient prognosis.

  • Identifying a better-prognosis pancreatic cancer from its benign inflammatory mimic: a machine learning approach with contrast-enhanced ultrasound for early intervention

    by Hua Liang, Ruiyang Gao, Yang Gui, Xueqi Chen, Tianjiao Chen, Li Tan, Wanying Jia, Menghua Dai, Weibin Wang, Junchao Guo, et al.

    Purpose Hypervascular pancreatic ductal adenocarcinoma (PDAC) and mass-forming pancreatitis (MFP) represent a classic diagnostic mimicry on contrast-enhanced ultrasound, as both exhibit similar arterial-phase hyperenhancement, precluding reliable visual distinction. Crucially, the hypervascular PDAC subtype is associated with a more favorable prognosis, rendering its accurate identification from its benign inflammatory mimic (MFP) a clinically significant priority for early and appropriate intervention. This study aimed to develop and validate a small-sample–oriented machine learning framework leveraging quantitative time-intensity curve (TIC) features to achieve this precise differentiation. Materials and methods We retrospectively included 152 patients with pathologically confirmed lesions who underwent CEUS between September 2017 and April 2024 (85 hypervascular PDAC, 67 MFP). A temporally separated split was used: 122 patients (2017–2022) formed the training cohort and 30 patients (2023–2024) served as the internal test cohort. Paired TICs were generated from the lesion and adjacent normal pancreatic parenchyma, and 22 quantitative difference/ratio features describing enhancement amplitude, temporal kinetics and curve morphology were extracted. Based on independent-samples t-tests and clinical interpretability, five representative TIC features were selected to train six classical classifiers (logistic regression, support vector machine, k-nearest neighbors, random forest, naïve Bayes, and decision tree). Model performance was assessed by stratified 10-fold cross-validation on the training cohort and by testing on the temporally separated cohort. Results In nested cross-validation, all models achieved AUCs of approximately 0.89–0.92. On the test cohort, AUCs ranged from about 0.83 to 0.92, with logistic regression performing best (AUC 0.915). Overall, the six classifiers showed broadly comparable discrimination. Conclusion A machine-learning model built on a small set of physiologically interpretable CEUS-TIC features can provide stable and explainable quantitative support for differentiating hypervascular PDAC from MFP, even under limited-sample conditions.

  • Open Access

    Development and validation of a nomogram model based on ultrasound and contrast-enhanced ultrasound features for differentiating mass-forming pancreatitis and pancreatic ductal adenocarcinoma

    by Hua Liang, Yang Gui, Xueqi Chen, Tianjiao Chen, Jing Zhang, Li Tan, Wanying Jia, Menghua Dai, Weibin Wang, Junchao Guo, et al.

    Purpose To explore the value of ultrasound (US) and contrast-enhanced ultrasound (CEUS) in differentiating mass-forming Pancreatitis (MFP) and pancreatic ductal adenocarcinoma (PDAC). Methods This retrospective study analyzed clinical and imaging data from 281 patients who underwent pancreatic CEUS between January 2018 and December 2023. Patients were randomly divided into training (n = 196) and validation (n = 85) sets. Logistic regression analyses were conducted to identify independent predictive imaging features for differentiating PDAC from MFP in the training set. Based on the identified predictors, two nomogram models were constructed: the US model and the US + CEUS model. The diagnostic performance of both models was assessed via the area under the receiver operating characteristic curve (AUC), calibration plots, Hosmer-Lemeshow test, and decision-curve analysis (DCA). Results Multivariate logistic regression analysis based on these factors identified taller-than-wide shape (P = 0.002, OR = 0.12), calcification (P = 0.003, OR = 13.76), and washout pattern (P = 0.002, OR = 0.13) as independent predictive factors for distinguishing PDAC from MFP. Compared to the US model, the US + CEUS model demonstrated better performance with AUC values 0.930 (95% CI: 0.895–0.965) in the training set and 0.914 (95% CI: 0.853–0.976) in the validation set. Calibration curve plots and the Hosmer-Lemeshow test (P > 0.05) confirmed that the model has good calibration, and DAC showed significant clinical benefit. Conclusion The nomogram model constructed using taller-than-wide shape, calcification, and washout pattern demonstrated excellent discriminative ability, accuracy, and clinical utility in differentiating PDAC from MFP.


  • Propensity score-matching analysis of retrograde artery first approach pancreatosplenectomy versus radical antegrade modular pancreatosplenectomy for ‘shoulder’ pancreatic cancers

    by Feng Tian, Jianlu Zhang, Kehan Jin, Yu Wang, Taiping Zhang, Junchao Guo

    Background ‘Shoulder’ pancreatic cancer is a challenging situation owing to its close proximity to the branches of the celiac artery and portal vein (PV). A pioneering study demonstrated the feasibility of retrograde artery first approach pancreatosplenectomy (RAFAPS) in treating ‘shoulder’ pancreatic cancer. However, comparative studies on this topic are lacking. Methods In this single-centre cohort study, we retrospectively enrolled consecutive ‘shoulder’ pancreatic cancer cases from September 2019 to May 2023. Based on propensity score-matching analysis, we compared the safety and short-term oncological outcomes between RAFAPS and radical antegrade modular pancreatosplenectomy (RAMPS) for ‘shoulder’ pancreatic cancers. The primary outcome was a negative retroperitoneal margin rate. Results In total, 135 (17.0%) ‘shoulder’ pancreatic cancers were identified among 794 pancreatic cancers during the study period. After matching based on body mass index, tumour size, distance from the right edge of the tumour to the left wall of the PV, and neoadjuvant chemotherapy, a cohort of 78 patients was selected for analysis (1:1 match, 39 per group). Invasion of splenic vein, splenic artery and PV were found in 40 (51.3%), 28 (35.9%) and 23 (29.5%) patients, respectively. RAFAPS was associated with a higher rate of negative retroperitoneal margins (100% vs 84.6%; relative risk = 1.18, 95% confidence interval [CI]: 1.034–1.351; P = 0.025) and less estimated blood loss (150 vs 300 ml; estimated difference: − 100 ml, 95% CI: − 200–0; P = 0.039) when compared to that of RAMPS. Conclusion RAFAPS is a safe and effective alternative to RAMPS for managing ‘shoulder’ pancreatic cancers in a minimally invasive era, with decreased blood loss and favourable retroperitoneal margin. Graphical abstract

  • Open Access

    Robot-assisted “Bridge” approach pancreatosplenectomy for “shoulder” pancreatic cancer: a new technique

    by Jianlu Zhang, Junchao Guo

    Pancreatic body/tail cancer has a worse prognosis because of late detection and early invasion into important vessels. Our team proposed the concept of “shoulder” pancreatic cancer (PC) and invented a new approach named retrograde artery first approach pancreatosplenectomy (RAFAPS). However, we found that in some cases, this approach may not be perfect. We encountered a patient who had previously undergone laparoscopic radical operation for hilar cholangiocarcinoma caused RAFAPS could not be performed. Hence, we used a new procedure based on RAFAPS to finish the pancreatosplenectomy and named it “Bridge.” After the operation, the patient recovered smoothly. We report the new technique, aiming to provide the experience for the surgical treatment of “shoulder” PC.

  • Open Access

    Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer

    by Jianzhou Liu, Jing Huang, Jun Lu, Runze Ouyang, Wenchao Xu, Jianlu Zhang, Kevin Chen-Xiao, Chengjun Wu, Dong Shang, Vay Liang W(Bill) Go, et al.


  • Open Access

    Local resection for solid pseudopapillary neoplasms of the pancreas shows improved postoperative gastrointestinal function and reduced mental stress: a multiquestionnaire survey from a large cohort

    by Yuze Hua, Xia Hong, Menghua Dai, Jiayi Li, Sen Yang, Junchao Guo, Weibin Wang, Qiang Xu, Xianlin Han, Mengyi Wang, et al.

    Background: Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare, low-grade malignant pancreatic tumor with a highly favorable prognosis. Most SPN patients are young and middle-aged women. The main controversial topic for SPN is local resection (LR) versus radical resection (RR). Theoretically, LR could lead to better gastrointestinal function (GIF) and less mental stress. However, no data is available to support this hypothesis. Methods: All SPN patients undergoing surgical treatment in Peking Union Medical College Hospital from 2001 to 2021 were included in the study. A cross-sectional online multiquestionnaire survey containing 110 questions was sent to them (Clinicaltrial.org, NCT05604716). This online multiquestionnaire survey focused on GIF and mental stress and consisted of eight questionnaires. Multiple linear regression analysis was conducted to identify independent factors impacting GIF and mental stress. Results: A total of 183 cases provided valid results. Among them, 46 patients (25.1%) underwent LR, and 137 (74.9%) underwent RR. Ninety-four cases (51.4%) underwent minimally invasive surgery (MIS), while 89 (48.6%) underwent open surgery. The average GSRS score of the patients was 1.9±0.7, indicating that most suffered from mild gastrointestinal dysfunction. The scores of PHQ-9 and GAD-7 in 16 patients (8.7%) and 27 (14.8%) patients, respectively, were beyond 10.0, which indicated clinical depression and anxiety. Additionally, 19 (10.4%) patients reported poor ability to work, and 31(16.9%) patients had significant body image concerns. Compared to other clinicopathological characteristics, LR (LR vs. RR: PHQ-9 score, P=0.018; WAI average score, P=0.010; EORTC QLQ-C30, nine subdomains, PP=0.006) and MIS (MIS vs. open surgery: EORTC QLQ-C30, three subdomains, PP=0.006) were the most significant factors predicting improved GIF and reduced mental stress. Conclusions: This study systematically presents postoperative GIF and mental stress of SPN patients using validated multiquestionnaires for the first time. It provides solid evidence that LR and MIS can improve GIF and reduce mental stress after surgery for SPN patients, which could be helpful for the surgeons to make more personalized surgical plans for their patients.


  • Open Access

    Application of metagenomic sequencing of drainage fluid in rapid and accurate diagnosis of postoperative intra-abdominal infection: a diagnostic study

    by Ruizhe Zhu, Xiafei Hong, Dong Zhang, Yi Xiao, Qiang Xu, Bin Wu, Junchao Guo, Xianlin Han, Qiwen Yang, Yupei Zhao, et al.

    Background: Postoperative intra-abdominal infection (PIAI) is one of the most serious complications of abdominal surgery, increasing the risk of postoperative morbidity and mortality and prolonging hospital stay. Rapid diagnosis of PIAI is of great clinical value. Unfortunately, the current diagnostic methods of PIAI are not fast and accurate enough. Methods: The authors performed an exploratory study to establish a rapid and accurate diagnostic method of PIAI. The authors explored the turnaround time and accuracy of metagenomic next-generation sequencing (mNGS) in diagnosing PIAI. Patients who underwent elective abdominal surgery and routine abdominal drainage with suspected PIAI were enroled in the study. The fresh midstream abdominal drainage fluid was collected for mNGS and culturing. Results: The authors found that the median sample-to-answer turnaround time of mNGS was dramatically decreased than that of culture-based methods (<24 h vs. 59.5–111 h). The detection coverage of mNGS was much broader than culture-based methods. The authors found 26 species from 15 genera could only be detected by mNGS. The accuracy of mNGS was not inferior to culture-based methods in the 8 most common pathogens detected from abdominal drainage fluid (sensitivity ranged from 75 to 100%, specificity ranged from 83.3 to 100%, and kappa values were higher than 0.5). Moreover, the composition of the microbial spectrum established by mNGS varied between upper and lower gastrointestinal surgery, enhancing the understanding of PIAI pathogenesis. Conclusion: This study preliminarily revealed the clinical value of mNGS in the rapid diagnosis of PIAI and provided a rationale for further research.


  • Open Access

    Robot-assisted pancreaticoduodenectomy in situs inversus totalis patient with pancreatic cancer

    by Jianlu Zhang, Yu Wang, Surong Hua, Junchao Guo

    Pancreatic cancer (PC) combined with situs inversus totalis (SIT) is rare, and the treatment strategy is obscure. We report the first patient with PC and SIT who underwent robot-assisted pancreaticoduodenectomy. A 57-year-old male patient presented to our hospital with epigastric pain, nausea, and weight loss over 1 month. Preoperative diagnostic modalities revealed a resectable pancreatic ductal adenocarcinoma at the head and neck junction of the pancreas. The patient also had a rare condition called SIT. Then, the patient underwent Da Vinci robot-assisted pancreaticoduodenectomy (RPD) in our center. After the operation, the patient recovered well without complications. Until now, the patient was followed up 5 months, and the quality of life was well without tumor recurrence or metastasis. To the authors’ knowledge, this is the first RPD for PC in SIT patients.